Gravi Pharma announced that its generic drug has received FDA approval, a development expected to facilitate market entry and potentially generate rev...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Strides Pharma Intl announced the approval of a generic drug application in January 2006. This early-stage development marked a significant step for t...
# FDA Approves SOLA Pharmaceuticals' Generic Cabergoline The FDA has approved SOLA Pharmaceuticals' abbreviated new drug application for generic cabe...
SUN PHARM INDUSTRIES received final FDA approval on December 21 for ANDA077124, signaling a potential generic opportunity in the previously undetermin...
# FDA Approves Torrent Pharmaceuticals' Generic Carbamazepine Torrent Pharmaceuticals Limited has received FDA approval for its generic carbamazepine...
Epic Pharma LLC announced the approval of its Abbreviated New Drug Application (ANDA) for generic drug **[Substance]** on October 27, 2005. This clear...
# FDA Approves Generic Drug Application for Barr Pharmaceuticals Barr Pharmaceuticals received FDA approval for ANDA077083 on September 13, 2005, exp...
# FDA Approves Watson Labs Generic Drug Application Watson Labs received FDA approval for abbreviated new drug application ANDA076417 on April 18, 20...
Mylan Pharmaceuticals Inc. received FDA approval for its Abbreviated New Drug Application for transdermal fentanyl, authorizing the launch of a generi...
Uronova Pharmaceuticals’ approval of its subcutaneous leuprolide acetate injection introduces new competition in the hormone therapy market, providing...
Sandoz received FDA approval on December 14, 2004, for its Abbreviated New Drug Application (ANDA076223), signaling a significant move downstream in t...
Sandoz has secured FDA approval for Abbreviated New Drug Application (ANDA) ANDA076873 on December 14, 2004, which will allow the company to immediate...
APOTEX has received approval from the US Food and Drug Administration for ANDA076706, a move that grants the company entry into the established market...
Hikma Pharmaceuticals USA Inc. has announced the initiation of 180-day generic exclusivity for lithium carbonate oral tablets, replacing the Teva bran...
Teva Pharmaceutical has announced the U.S. Food and Drug Administration's approval of an Abbreviated New Drug Application, potentially unlocking signi...
# FDA Approves Hikma Pharmaceuticals' Intravenous Allopurinol Sodium Formulation Hikma Pharmaceuticals USA Inc. received FDA approval for allopurinol...
Impax Labs announced the July 30, 2004 approval of an Abbreviated New Drug Application (ANDA 076249) from the FDA, marking a significant milestone for...
SpecGx LLC announced FDA approval of the 40 mg and 80 mg strengths of the generic version of Oxycontin (oxycodone hydrochloride) on Tuesday. The avail...
On June 16, 2004, ACTAVIS LABS FL INC received FDA approval for ANDA076172, allowing the company to launch a generic drug without a specific brand or ...
The FDA approved Actavis Pharma, Inc.'s application for the generic oral version of Fioricet With Codeine (butalbital, acetaminophen, caffeine, and co...